United States Antimony Corporation engages in the production of antimony and zeolite, operating in the primary smelting and refining of nonferrous metals.
It occupies a unique position as one of the few significant domestic producers of antimony, a critical mineral for national defense and industry.
Updated: January 14, 2026, 16:00 EST
Technical Perspective UAMY displays extreme volatility, with sharp monthly gains sharply contrasting with significant three-month declines and substantial underperformance against the broader market. Trading in the lower portion of its 52-week range and possessing a negative beta, its price action appears driven by speculative forces rather than sustainable trends. This technical profile suggests high risk and unpredictable short-term movements.
Fundamental Health Fundamentally, UAMY is concerning. While the company has minimal debt and strong liquidity on paper, it is severely unprofitable and experiencing negative cash flow from operations. Key efficiency metrics like Return on Equity and Asset Turnover are deeply negative, indicating the business is not effectively generating value from its resources. The recent swing into a significant operating loss underscores fundamental weakness.
Valuation & Risk Assessment Valuation metrics are alarming, with deeply negative P/E and EV/EBITDA ratios alongside extremely high Price-to-Sales and Price-to-Book ratios, signaling overvaluation despite the lack of profitability. The primary risks include extreme price volatility, a massive maximum drawdown, and the cash-burning nature of its operations, which raises sustainability concerns absent a major turnaround.
---
Avoid / Sell. UAMY presents a highly speculative and risky profile that is difficult to justify for most investors. The combination of severe fundamental weaknesses, including persistent unprofitability and negative cash flow, with extreme valuation metrics and volatile price action, outweighs any potential upside from its recent bounce. Investors should seek opportunities with clearer paths to profitability and more stable financial foundations. This stock is suitable only for those with a very high risk tolerance and a speculative mandate.
*Note: This is not investment advice, for reference only.*
Of course. Here is a 12-month outlook for U.S. Antimony Corp. (UAMY) based on the provided analysis.
The outlook for UAMY over the next year is highly speculative and hinges on external catalysts rather than internal financial improvement. The primary catalyst would be a significant, sustained rise in antimony prices, driven by its strategic importance in military alloys and flame retardants, which could re-ignite investor speculation. However, the major risks are substantial, including the company's persistent unprofitability, negative cash flow, and extreme share price volatility, which make it vulnerable to sharp downturns if speculative interest wanes. Given the absence of a reliable analyst target and the company's weak fundamentals, the stock is expected to remain highly volatile with a wide potential range, heavily influenced by commodity sentiment rather than corporate performance. Investors should approach with extreme caution.
Most Wall Street analysts are optimistic about UAMY's 12-month outlook, with consensus target around $8.78, indicating expected upside potential.
Overall, UAMY has investment potential but also faces challenges. Here are key factors to weigh before investing.
Overall Assessment: UAMY exhibits extreme volatility with significant recent gains but substantial long-term underperformance against the broader market.
Short-term Performance: The stock has surged 29% over the past month, sharply contrasting with its 29% three-month decline, while significantly underperforming the market by 32 percentage points over the latter period. This divergent short-term momentum suggests heightened speculative activity rather than fundamental strength.
Current Position: Trading at $7.75 places UAMY in the lower 36% of its 52-week range ($1.21-$19.71), indicating potential oversold conditions despite the recent rally. With a negative beta of -0.006, the stock moves inversely to market trends and remains 61% below its yearly peak despite the monthly surge.
| Period | UAMY Return | S&P 500 |
|---|---|---|
| 1m | +56.8% | +1.3% |
| 3m | -28.1% | +5.7% |
| 6m | +288.5% | +10.6% |
| 1y | +404.6% | +16.5% |
| ytd | +48.1% | +1.1% |
Of course. Here is a fundamental analysis of UAMY based on the provided data.
UAMY displays significant volatility in its financial performance. While revenue was substantial in Q2 2025 at $10.5 million, it declined to $8.7 million in Q3. More concerning is the sharp deterioration in profitability; the company swung from a slight operating profit in Q2 to a significant operating loss in Q3, resulting in a negative net income margin of -54.9%. This indicates severe pressure on the bottom line, driven by operating expenses that far exceeded gross profit in the most recent quarter.
The company's balance sheet shows a strong liquidity position with a high current ratio of 5.08 and a very low debt ratio of 0.33%, suggesting minimal leverage. However, this apparent strength is overshadowed by a critical weakness in cash flow. The cash flow to debt ratio is deeply negative at -14.57, and the operating cash flow per share is also negative, indicating the company is burning cash to fund its operations. This creates a reliance on existing cash reserves or external financing despite the low debt level.
Operational efficiency is a major concern. The return on equity (ROE) and return on assets (ROA) are both negative at -6.66% and -5.98%, respectively, signaling that the company is not generating value from its equity or asset base. Furthermore, the asset turnover ratio is very low at 0.11, implying inefficient use of assets to generate sales. The lengthy cash conversion cycle of 76 days points to capital being tied up in operations for an extended period, further straining liquidity.
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Try Now & Get Tesla Stock RewardValuation Level: UAMY exhibits deeply negative valuation metrics with a TTM PE of -193.75 and EV/EBITDA of -166.0, indicating the company is currently unprofitable. The extreme PB ratio of 15.13 and PS ratio of 32.79 suggest significant overvaluation relative to the company's book value and sales. While the PEG ratio appears favorable at 0.014, this metric is questionable given the fundamental lack of profitability.
Peer Comparison: Without industry average data available, a direct peer comparison cannot be performed. However, given UAMY's negative earnings metrics and exceptionally high valuation ratios relative to its own fundamentals, the stock appears substantially overvalued on an absolute basis. Investors should approach with caution until profitability improves or comparative industry benchmarks become available.
UAMY's beta of -0.006 indicates it moves inversely to the market, but with almost no correlation, suggesting its price action is driven by idiosyncratic factors rather than systemic market moves. The extreme maximum drawdown of -74.3% over the past year highlights severe volatility and substantial downside risk, indicating the stock has experienced significant price erosion independent of general market conditions.
The absence of reported short interest is unusual and could point to extremely low liquidity or a limited float, which may exacerbate volatility and create execution challenges for trades. This lack of market attention, combined with the dramatic drawdown, suggests potential fundamental issues or a highly speculative profile that warrants cautious due diligence.
Opinion: Bearish
Core Reasons: 1. Financial distress - Negative earnings, cash flow, and ROE/ROA indicate fundamental weakness 2. Extreme volatility - 74% drawdown with speculative price swings unrelated to market trends 3. Questionable valuation - Negative P/E and extremely high P/S ratio suggest overvaluation
Suitable For: Speculative traders comfortable with high-risk micro-caps; unsuitable for most investors given the fundamental deterioration and cash burn.
Bottom Line: Despite being the sole US antimony producer, the company's financial health and operational efficiency raise serious concerns that outweigh strategic positioning benefits.
Based on the provided data, UAMY stock appears substantially overvalued.
The valuation metrics are alarming: a deeply negative trailing P/E of -193.75 and a Price-to-Book (P/B) ratio of 15.13, which is exceptionally high and suggests the market price is significantly disconnected from the company's net asset value. The Price-to-Sales (P/S) ratio of 32.79 is also extremely elevated, indicating investors are paying a premium for sales that are not translating into profitability.
The primary reason for this overvaluation is the company's fundamentally weak financial state. UAMY is unprofitable (with negative net income and operating cash flow), exhibits poor operational efficiency (negative ROE/ROA, low asset turnover), and is burning through cash. While the low PEG ratio might suggest growth potential, it is an unreliable metric when earnings are negative. The stock's price seems to be supported by speculative factors rather than sound financial fundamentals.
Of course. Based on the provided information, here are the key risks of holding UAMY stock, ordered by importance.
The company is experiencing severe operational distress, characterized by a rapid swing to significant operating losses, negative cash flow from operations, and deeply negative returns on equity and assets, which indicates a fundamental inability to generate value or sustain itself without relying on existing cash reserves.
The stock exhibits extreme, idiosyncratic price swings—including a 74.3% maximum drawdown and a recent 29% surge—driven by speculative activity rather than fundamental improvement, a pattern that is exacerbated by indications of very low liquidity and a limited float, posing high execution and valuation risks.
Inefficient operations are evidenced by a very low asset turnover ratio, suggesting weak revenue generation relative to its asset base, and a lengthy 76-day cash conversion cycle, which strains liquidity by keeping capital tied up in working capital for extended periods.
With a beta near zero (-0.006), the stock's price movement is completely disconnected from broader market trends, depriving investors of the diversification benefits typically associated with equity holdings and making the investment entirely dependent on unpredictable company-specific factors.
Of course. Here is a forecast for U.S. Antimony Corp. (UAMY) through 2026.
1. Target Price Range: * Base Case (2026): $5.00 - $9.00 * Bull Case (2026): $12.00 - $18.00
2. Key Growth Drivers: * Strategic Metal Demand: Increased global demand for antimony in military applications, flame retardants, and particularly as a anode material in next-generation lithium-ion batteries. * Supply Chain Consolidation: UAMY's position as the only significant antimony producer in the Western Hemisphere could attract strategic interest or government support. * Commodity Price Spike: A sustained, sharp increase in the global price of antimony would directly boost revenue and investor sentiment.
3. Main Assumptions: * The forecast assumes the company can stabilize its operations and manage its cash burn. * It is predicated on a significant uptick in antimony prices, without which the fundamental weaknesses are likely to persist. * The bull case requires a major catalyst, such as a breakthrough in battery technology or a substantial supply disruption.
4. Uncertainty: This forecast is exceptionally speculative. UAMY's trajectory is less dependent on its operational execution and more on volatile commodity prices and speculative investor sentiment, making any price target highly uncertain.